Tag: Alkem
Alkem signs licensing deal with Sonnet BioTherapeutics to launch its drug...
Sonnet’s drug candidate “SON-080” has shown encouraging data in phase 1b clinical trial
Alkem MedTech partners Exactech to manufacture & market knee-hip replacement implants...
This collaboration marks the first of its kind in the musculoskeletal space in India, providing Alkem MedTech with access to the design, manufacturing expertise, and marketing rights of Exactech's globally-recognized brands
World COPD Day: Alkem Healthy Lungs Initiative promotes importance of inhalation...
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
Enzene Biosciences launches Cetuximab: the first biosimilar of cancer treatment drug...
Cetuximab is the first biosimilar in the world, of cancer treatment drug Erbitux
Alkem launches novel antibiotic for multiple drug resistance infections
With the rise in infections caused by carbapenem-resistant Gram-negative organisms in India, there is a need for more effective antibiotic treatment
DigiHealth to invest in developing a world-class supply chain & distribution...
The investment has been made with a view to develop a world-class pharmaceutical supply chain & distribution IT ecosystem and support the government’s National Digital Health Mission.............................
Stempeutics sells marketing rights for its stem cell therapy product to...
Under this agreement, Alkem will get the exclusive marketing rights for Stempeucel in India for Osteoarthritis with Stempeutics manufacturing and supplying the product to the company.............